BIO Suggests Re-Evaluation Of Continuous Marketing Application Programs
FDA's continuous marketing application pilot programs may not be worth continuing, the Biotechnology Industry Organization suggested
FDA's continuous marketing application pilot programs may not be worth continuing, the Biotechnology Industry Organization suggested